BioXcel Therapeutics Announces Journal of the American Medical Association Publication of Data from SERENITY II Pivotal Phase 3 Trial Evaluating BXCL501 in Bipolar Disorders
BXCL501 demonstrated statistically significant and clinically meaningful improvements in primary and key secondary efficacy measures…
Liontown Selects InEight Document to Support Mining Project Information Management